Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector

Experimental Hematology

Volumn 41, Issue 1, 2013, Pages

  Cornils, Kerstin ^a   Bartholomae, Cynthia C ^b   Thielecke, Lars ^c   Lange, Claudia ^a   Arens, Anne ^b   Glauche, Ingmar ^c   Mock, Ulrike ^a   Riecken, Kristoffer ^a   Gerdes, Sebastian ^c   von Kalle, Christof ^b   Schmidt, Manfred ^b   Roeder, Ingo ^c   Fehse, Boris ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; RETROVIRUS VECTOR;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CLONING; CLONAL RECONSTITUTION KINETICS; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENHANCER REGION; FEMALE; GENE INSERTION; GENE VECTOR; GENETIC MARKER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LINEAR AMPLIFICATION MEDIATED POLYMERASE CHAIN REACTION; LONG TERMINAL REPEAT; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESTRICTION MAPPING;

EID: 84870876227     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.09.003     Document Type: Article

References (51)

1. Jordan C.T., Lemischka I.R. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev 1990, 4:220-232.
2. Li Z., Düllmann J., Schiedlmeier B., et al. Murine leukemia induced by retroviral gene marking. Science 2002, 296:497.
3. Kustikova O., Fehse B., Modlich U., et al. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 2005, 308:1171-1174.
4. Enssle J., Trobridge G.D., Keyser K.A., et al. Stable marking and transgene expression without progression to monoclonality in canine long-term hematopoietic repopulating cells transduced with lentiviral vectors. Hum Gene Ther 2010, 21:397-403.
5. Calmels B., Ferguson C., Laukkanen M.O., et al. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood 2005, 106:2530-2533.
6. Tey S.K., Brenner M.K. The continuing contribution of gene marking to cell and gene therapy. Mol Ther 2007, 15:666-676.
7. Barese C.N., Dunbar C.E. Contributions of gene marking to cell and gene therapies. Hum Gene Ther 2011, 22:659-668.
8. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302:415-419.
9. Hacein-Bey-Abina S., von Kalle C., Schmidt M., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003, 348:255-256.
10. Hacein-Bey-Abina S., Garrigue A., Wang G.P., et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 2008, 118:3132-3142.
11. Howe S.J., Mansour M.R., Schwarzwaelder K., et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008, 118:3143-3150.
12. Stein S., Ott M.G., Schultze-Strasser S., et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1activation after gene therapy for chronic granulomatous disease. Nat Med 2010, 16:198-204.
13. Wang G.P., Garrigue A., Ciuffi A., et al. DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer. Nucleic Acids Res 2008, 36:e49.
14. Cartier N., Hacein-Bey-Abina S., Bartholomae C.C., et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009, 326:818-823.
15. Cavazzana-Calvo M., Payen E., Negre O., et al. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 2010, 467:318-322.
16. Boztug K., Schmidt M., Schwarzer A., et al. Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med 2010, 363:1918-1927.
17. Biffi A., Bartolomae C.C., Cesana D., et al. Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 2011, 117:5332-5339.
18. Kustikova O.S., Schiedlmeier B., Brugman M.H., et al. Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis. Mol Ther 2009, 17:1537-1547.
19. Maetzig T., Brugman M.H., Bartels S., et al. Polyclonal fluctuation of lentiviral vector-transduced and expanded murine hematopoietic stem cells. Blood 2011, 117:3053-3064.
20. Kustikova O.S., Geiger H., Li Z., et al. Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways. Blood 2007, 109:1897-1907.
21. Kustikova O.S., Modlich U., Fehse B. Retroviral insertion site analysis in dominant haematopoietic clones. Methods Mol Biol 2009, 506:373-390.
22. Schmidt M., Schwarzwaelder K., Bartholomae C., et al. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods 2007, 4:1051-1057.
23. Harkey M.A., Kaul R., Jacobs M.A., et al. Multiarm high-throughput integration site detection: limitations of LAM-PCR technology and optimization for clonal analysis. Stem Cells Dev 2007, 16:381-392.
24. Gabriel R., Eckenberg R., Paruzynski A., et al. Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med 2009, 15:1431-1436.
25. Brady T., Roth S.L., Malani N., et al. A method to sequence and quantify DNA integration for monitoring outcome in gene therapy. Nucleic Acids Res 2011, 39:e72.
26. Li Z., Schwieger M., Lange C., et al. Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose. Exp Hematol 2003, 31:1206-1214.
27. Cornils K., Lange C., Schambach A., et al. Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance. Mol Ther 2009, 17:131-143.
28. Weber K., Bartsch U., Stocking C., Fehse B. A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. Mol Ther 2008, 16:698-706.
29. Zufferey R., Dull T., Mandel R.J., et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998, 72:9873-9880.
30. Schambach A., Bohne J., Baum C., et al. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther 2006, 13:641-645.
31. Schambach A., Galla M., Modlich U., et al. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research. Exp Hematol 2006, 34:588-592.
32. Paruzynski A., Arens A., Gabriel R., et al. Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat Protoc 2010, 5:1379-1395.
33. Hoffmann S., Otto C., Kurtz S., et al. Fast mapping of short sequences with mismatches, insertions and deletions using index structures. PLoS Comput Biol 2009, 5:e1000502.
34. Bystrykh L.V., Verovskaya E., Zwart E., Broekhuis M., de Haan G. Counting stem cells: methodological constraints. Nat Methods 2012, 96:567-574.
35. Edgar R.C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010, 26:2460-2461.
36. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
37. Akagi K., Suzuki T., Stephens R.M., Jenkins N.A., Copeland N.G. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 2004, 32(Database issue):D523-527.
38. Kustikova O.S., Baum C., Fehse B. Retroviral integration site analysis in hematopoietic stem cells. Methods Mol Biol 2008, 430:255-267.
39. Bozorgmehr F., Laufs S., Sellers S.E., et al. No evidence of clonal dominance in primates up to 4 years following transplantation of multidrug resistance 1 retrovirally transduced long-term repopulating cells. Stem Cells 2007, 25:2610-2618.
40. Kustikova O.S., Wahlers A., Kuhlcke K., et al. Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood 2003, 102:3934-3937.
41. Cattoglio C., Maruggi G., Bartholomae C., et al. High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. PLoS One 2010, 5:e15688.
42. Roeder I., Horn K., Sieburg H.B., Cho R., Muller-Sieburg C., Loeffler M. Characterization and quantification of clonal heterogeneity among hematopoietic stem cells: a model-based approach. Blood 2008, 112:4874-4883.
43. Drize N., Chertkov J., Sadovnikova E., Tiessen S., Zander A. Long-term maintenance of hematopoiesis in irradiated mice by retrovirally transduced peripheral blood stem cells. Blood 1997, 89:1811-1817.
44. Gerrits A., Dykstra B., Kalmykowa O.J., et al. Cellular barcoding tool for clonal analysis in the hematopoietic system. Blood 2010, 115:2610-2618.
45. Bieniasz P.D., Cullen B.R. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol 2000, 74:9868-9877.
46. Tervo H.M., Goffinet C., Keppler O.T. Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration. Retrovirology 2008, 5:58.
47. Shabram P., Aguilar-Cordova E. Multiplicity of infection/multiplicity of confusion. Mol Ther 2000, 2:420-421.
48. Fehse B., Kustikova O.S., Bubenheim M., Baum C. Pois(s)on-it's a question of dose. Gene Ther 2004, 11:879-881.
49. Schepers K., Swart E., van Heijst J.W., et al. Dissecting T cell lineage relationships by cellular barcoding. J Exp Med 2008, 205:2309-2318.
50. Lu R., Neff N.F., Quake S.R., Weissman I.L. Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding. Nat Biotechnol 2011, 29:928-933.
51. Glimm H., Ball C.R., von Kalle C. You can count on this: barcoded hematopoietic stem cells. Cell Stem Cell 2011, 9:390-392.